Hepatitis C virus and lipids in the era of direct acting antivirals (DAAs)

David A. Sheridan^*, R. Dermot G. Neely, Margaret F. Bassendine

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	10-16
Number of pages	0
Journal	Clinics and Research in Hepatology and Gastroenterology
Volume	37
Issue number	1
DOIs	https://doi.org/10.1016/j.clinre.2012.07.002
Publication status	Published - Feb 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{29fe15152084423f8dd9e8fce240b581,

title = "Hepatitis C virus and lipids in the era of direct acting antivirals (DAAs)",

author = "Sheridan, {David A.} and Neely, {R. Dermot G.} and Bassendine, {Margaret F.}",

year = "2013",

month = feb,

doi = "10.1016/j.clinre.2012.07.002",

language = "English",

volume = "37",

pages = "10--16",

journal = "Clinics and Research in Hepatology and Gastroenterology",

issn = "2210-7401",

publisher = "Elsevier Masson s.r.l.",

number = "1",

}

TY - JOUR

T1 - Hepatitis C virus and lipids in the era of direct acting antivirals (DAAs)

AU - Sheridan, David A.

AU - Neely, R. Dermot G.

AU - Bassendine, Margaret F.

PY - 2013/2

Y1 - 2013/2

U2 - 10.1016/j.clinre.2012.07.002

DO - 10.1016/j.clinre.2012.07.002

M3 - Article

SN - 2210-7401

VL - 37

SP - 10

EP - 16

JO - Clinics and Research in Hepatology and Gastroenterology

JF - Clinics and Research in Hepatology and Gastroenterology

IS - 1

ER -